EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polyethylene glycol 35 preserves endothelial barrier integrity by stabilizing the glycocalyx and intercellular junctions

Andrea Llaves-López iD, Queralt Barnat-Cabrera, Paula Manso-Álvarez, Joana Ferrer-Fàbrega iD, Carme Casal, Emma Folch-Puy iD

Bioscience Reports · 18.11.2026 · 46 (11)

DOI: 10.1042/bsr20260686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 11.11.2026. Verfasst von Andrea Llaves-López und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pathology, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, Barcelona, Spain. Hauptthemen laut MEDLINE: Glycocalyx, Polyethylene Glycols, Human Umbilical Vein Endothelial Cells, Intercellular Junctions. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación (MCIN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction is a hallmark of numerous inflammatory and ischemic conditions, characterized by increased permeability, disruption of intercellular junctions and endothelial glycocalyx (eGCX) degradation. In the present study, we investigated the ability of polyethylene glycol 35 (PEG35) to preserve endothelial barrier integrity in cultured human umbilical vein endothelial cells (HUVECs) exposed to inflammatory, thrombotic, hypoxia-mimetic, and eGCX-disrupting stimuli. PEG35 mitigated the loss of cellular metabolic activity induced by apoptotic and hypoxia-mimetic stress. Functionally, PEG35 attenuated stimulus-induced increases in FITC-dextran permeability and helped maintain trans-endothelial electrical resistance (TEER) under pro-inflammatory and eGCX-disrupting agents. PEG35 also reduced LDH release and maintained higher TEER values in endothelial cells exposed to plasma collected from pancreas transplant recipients after reperfusion, which contained increased circulating levels of the eGCX component syndecan-1. Mechanistically, PEG35 reduced NF-κB p65 nuclear translocation under thrombin, tumor necrosis factor α, and hyaluronidase stimulation and attenuated inflammatory and endothelial activation-related transcriptional responses. PEG35 also modulated intercellular junction gene expression in a stimulus and target-dependent manner, helped maintain occludin and claudin-5 protein expression under selected injurious conditions, and limited the loss of eGCX-associated syndecan-1 and heparan sulfate staining after enzymatic degradation. Collectively, these findings support a multifactorial endothelial-protective effect of PEG35 involving preservation of the endothelial surface layer, maintenance of junctional integrity, and attenuation of inflammatory signalling. These results identify PEG35 as a potential vasoprotective candidate for conditions involving acute endothelial barrier injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxPolyethylene GlycolsHuman Umbilical Vein Endothelial CellsIntercellular JunctionsHumansTranscription Factor RelATumor Necrosis Factor-alpha

Stichwörter der Autor:innen

adherens junctionendothelial barrierendothelial glycocalyxpolyethylene glycolstight junctionsvascular integrity

Substanzen

Polyethylene GlycolsTranscription Factor RelATumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Experimental Pathology, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Doctoral programme in Biomedicine, Universitat de Barcelona (UB), Barcelona, Spain.
  • Hepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Institute Clínic of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic, Universitat de Barcelona, Barcelona, Sp…
  • Network for Biomedical Research in Hepatic and Digestive Diseases (CIBEREHD), Barcelona, Spain.
  • Microscopy Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, Barcelona, Spain.

ORCID-Profile: Andrea Llaves-López, Joana Ferrer-Fàbrega, Emma Folch-Puy

Förderung

  • Ministerio de Ciencia e Innovación (MCIN)

Zitieren

APA

Llaves-López, A., Barnat-Cabrera, Q., Manso-Álvarez, P., Ferrer-Fàbrega, J., Casal, C., & Folch-Puy, E. (2026). Polyethylene glycol 35 preserves endothelial barrier integrity by stabilizing the glycocalyx and intercellular junctions. Bioscience Reports, 46(11). https://doi.org/10.1042/bsr20260686

Vancouver

Llaves-López A, Barnat-Cabrera Q, Manso-Álvarez P, Ferrer-Fàbrega J, Casal C, Folch-Puy E. Polyethylene glycol 35 preserves endothelial barrier integrity by stabilizing the glycocalyx and intercellular junctions. Bioscience Reports. 2026;46(11). doi:10.1042/bsr20260686

BibTeX
@article{LlavesLpez2026,
  author = {Llaves-López, Andrea and Barnat-Cabrera, Queralt and Manso-Álvarez, Paula and Ferrer-Fàbrega, Joana and Casal, Carme and Folch-Puy, Emma},
  title = {Polyethylene glycol 35 preserves endothelial barrier integrity by stabilizing the glycocalyx and intercellular junctions},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1042/bsr20260686}
}
Kostenlos starten →